1. Home
  2. BWEN vs CUE Comparison

BWEN vs CUE Comparison

Compare BWEN & CUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Broadwind Inc.

BWEN

Broadwind Inc.

HOLD

Current Price

$3.79

Market Cap

49.1M

Sector

Industrials

ML Signal

HOLD

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$0.39

Market Cap

49.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BWEN
CUE
Founded
N/A
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
49.1M
49.6M
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
BWEN
CUE
Price
$3.79
$0.39
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$6.00
$3.00
AVG Volume (30 Days)
256.7K
1.7M
Earning Date
11-13-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
63.89
N/A
EPS
0.23
N/A
Revenue
$153,877,000.00
$7,100,000.00
Revenue This Year
$11.68
N/A
Revenue Next Year
N/A
$25.00
P/E Ratio
$16.33
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.41
$0.23
52 Week High
$3.85
$1.60

Technical Indicators

Market Signals
Indicator
BWEN
CUE
Relative Strength Index (RSI) 68.51 46.78
Support Level $2.79 $0.23
Resistance Level $3.85 $0.44
Average True Range (ATR) 0.22 0.05
MACD 0.05 0.02
Stochastic Oscillator 94.34 75.71

Price Performance

Historical Comparison
BWEN
CUE

About BWEN Broadwind Inc.

Broadwind Inc is a precision manufacturer of structures, equipment and components for clean technology and other specialized applications. The company provide technologically high value products to customers with complex systems and stringent quality standards that operate in energy, mining and infrastructure sectors, in the United States of America. It capabilities include heavy fabrications, welding, metal rolling, coatings, gear cutting and shaping, gearbox manufacturing and repair, heat treat, assembly, engineering and packaging solutions. It operates through four operating segments namely Heavy Fabrications, Gearing, Industrial Solutions and Corporate.

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

Share on Social Networks: